Skip to main content
Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.400
+0.010 (0.42%)
At close: Apr 28, 2026, 4:00 PM EDT
2.345
-0.055 (-2.28%)
Pre-market: Apr 29, 2026, 8:36 AM EDT

Organogenesis Holdings Revenue

In the year 2025, Organogenesis Holdings had annual revenue of $564.17M with 17.04% growth. Organogenesis Holdings had revenue of $225.61M in the quarter ending December 31, 2025, with 78.13% growth.

Revenue (ttm)
$564.17M
Revenue Growth
+17.04%
P/S Ratio
0.55
Revenue / Employee
$660,619
Employees
854
Market Cap
308.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025564.17M82.13M17.04%
Dec 31, 2024482.04M48.90M11.29%
Dec 31, 2023433.14M-17.75M-3.94%
Dec 31, 2022450.89M-16.47M-3.52%
Dec 31, 2021467.36M129.06M38.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 742.90M
Esperion Therapeutics 403.14M
Evolus 297.18M
Aurora Cannabis 272.13M
Akebia Therapeutics 236.20M
Organigram Global 204.21M
Canopy Growth 203.04M
Kamada 180.46M
Revenue Rankings

ORGO News

More News